SkylineDx to Present Data on Precision Molecular Diagnostics Advances in Cutaneous Squamous Cell Carcinoma at 22nd EADO Congress

New gene-signature for cutaneous squamous cell carcinoma (CSCC) demonstrates ability to identify a subset of patients with higher risk of developing metastasis, outperforming existing staging systems ROTTERDAM, Netherlands and SAN DIEGO, April 23, 2026 /PRNewswire/ -- SkylineDx, an...